AssetID: 55779204
Headline: UNCAPTIONED: Novo Nordisk Moves Closer To Launching Wegovy Pill In China
Caption: Novo Nordisk Moves Closer To Launching Wegovy Pill In China. Novo Nordisk says it plans to seek regulatory approval in China for its oral version of the weight-loss drug Wegovy within the next few months. The move comes as Novo Nordisk races to compete with rival Eli Lilly in the rapidly growing obesity treatment market. Weight-loss pills are seen as a potentially attractive alternative for patients who prefer not to use injections. Novo has already received approval for the Wegovy pill in the United States and Britain while Eli Lilly has submitted its own oral weight-loss treatment for approval in China. Competition in the Chinese market is increasing, with both international and domestic drugmakers developing similar treatments. Novo’s chief executive said the company believes its manufacturing scale will provide a competitive advantage as demand for GLP-1 weight-loss medicines continues to grow. Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT
Keywords: Health & Wellbeing,Novo Nordisk,moves,c.oser,launching,wegovy pill,China,regulatory approval,oral version,injection,patients,obesity treatment market,Eli Lilly,rival,alternative,United States,Britain,lose weight,safely
PersonInImage: